IBDEI1Y4 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,32575,1,3,0)
 ;;=3^Phencyclidine Use Disorder,Mild
 ;;^UTILITY(U,$J,358.3,32575,1,4,0)
 ;;=4^F16.10
 ;;^UTILITY(U,$J,358.3,32575,2)
 ;;=^5003323
 ;;^UTILITY(U,$J,358.3,32576,0)
 ;;=F16.20^^143^1546^2
 ;;^UTILITY(U,$J,358.3,32576,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32576,1,3,0)
 ;;=3^Phencyclidine Use Disorder,Moderate-Severe
 ;;^UTILITY(U,$J,358.3,32576,1,4,0)
 ;;=4^F16.20
 ;;^UTILITY(U,$J,358.3,32576,2)
 ;;=^5003336
 ;;^UTILITY(U,$J,358.3,32577,0)
 ;;=F16.21^^143^1546^3
 ;;^UTILITY(U,$J,358.3,32577,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32577,1,3,0)
 ;;=3^Phencyclidine Use Disorder,Moderate-Severe,In Remission
 ;;^UTILITY(U,$J,358.3,32577,1,4,0)
 ;;=4^F16.21
 ;;^UTILITY(U,$J,358.3,32577,2)
 ;;=^5003337
 ;;^UTILITY(U,$J,358.3,32578,0)
 ;;=F11.10^^143^1547^4
 ;;^UTILITY(U,$J,358.3,32578,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32578,1,3,0)
 ;;=3^Opioid Use Disorder,Mild
 ;;^UTILITY(U,$J,358.3,32578,1,4,0)
 ;;=4^F11.10
 ;;^UTILITY(U,$J,358.3,32578,2)
 ;;=^5003114
 ;;^UTILITY(U,$J,358.3,32579,0)
 ;;=F11.129^^143^1547^3
 ;;^UTILITY(U,$J,358.3,32579,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32579,1,3,0)
 ;;=3^Opioid Intoxication w/o Perceptual Disturbances;Mild Use Disorder
 ;;^UTILITY(U,$J,358.3,32579,1,4,0)
 ;;=4^F11.129
 ;;^UTILITY(U,$J,358.3,32579,2)
 ;;=^5003118
 ;;^UTILITY(U,$J,358.3,32580,0)
 ;;=F11.14^^143^1547^8
 ;;^UTILITY(U,$J,358.3,32580,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32580,1,3,0)
 ;;=3^Opioid-Induced Depressive Disorder w/ Mild Use Disorder
 ;;^UTILITY(U,$J,358.3,32580,1,4,0)
 ;;=4^F11.14
 ;;^UTILITY(U,$J,358.3,32580,2)
 ;;=^5003119
 ;;^UTILITY(U,$J,358.3,32581,0)
 ;;=F11.182^^143^1547^10
 ;;^UTILITY(U,$J,358.3,32581,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32581,1,3,0)
 ;;=3^Opioid-Induced Sleep Disorder w/ Mild Use Disorder
 ;;^UTILITY(U,$J,358.3,32581,1,4,0)
 ;;=4^F11.182
 ;;^UTILITY(U,$J,358.3,32581,2)
 ;;=^5003124
 ;;^UTILITY(U,$J,358.3,32582,0)
 ;;=F11.20^^143^1547^5
 ;;^UTILITY(U,$J,358.3,32582,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32582,1,3,0)
 ;;=3^Opioid Use Disorder,Moderate-Severe
 ;;^UTILITY(U,$J,358.3,32582,1,4,0)
 ;;=4^F11.20
 ;;^UTILITY(U,$J,358.3,32582,2)
 ;;=^5003127
 ;;^UTILITY(U,$J,358.3,32583,0)
 ;;=F11.21^^143^1547^6
 ;;^UTILITY(U,$J,358.3,32583,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32583,1,3,0)
 ;;=3^Opioid Use Disorder,Moderate-Severe,In Remission
 ;;^UTILITY(U,$J,358.3,32583,1,4,0)
 ;;=4^F11.21
 ;;^UTILITY(U,$J,358.3,32583,2)
 ;;=^5003128
 ;;^UTILITY(U,$J,358.3,32584,0)
 ;;=F11.23^^143^1547^7
 ;;^UTILITY(U,$J,358.3,32584,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32584,1,3,0)
 ;;=3^Opioid Withdrawal
 ;;^UTILITY(U,$J,358.3,32584,1,4,0)
 ;;=4^F11.23
 ;;^UTILITY(U,$J,358.3,32584,2)
 ;;=^5003133
 ;;^UTILITY(U,$J,358.3,32585,0)
 ;;=F11.24^^143^1547^9
 ;;^UTILITY(U,$J,358.3,32585,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32585,1,3,0)
 ;;=3^Opioid-Induced Depressive Disorder w/ Moderate-Severe Use Disorder
 ;;^UTILITY(U,$J,358.3,32585,1,4,0)
 ;;=4^F11.24
 ;;^UTILITY(U,$J,358.3,32585,2)
 ;;=^5003134
 ;;^UTILITY(U,$J,358.3,32586,0)
 ;;=F11.29^^143^1547^2
 ;;^UTILITY(U,$J,358.3,32586,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32586,1,3,0)
 ;;=3^Opioid Dependence w/ Unspec Opioid-Induced Disorder
 ;;^UTILITY(U,$J,358.3,32586,1,4,0)
 ;;=4^F11.29
 ;;^UTILITY(U,$J,358.3,32586,2)
 ;;=^5003141
 ;;^UTILITY(U,$J,358.3,32587,0)
 ;;=F11.220^^143^1547^1
 ;;^UTILITY(U,$J,358.3,32587,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32587,1,3,0)
 ;;=3^Opioid Dependence w/ Intoxication,Uncomplicated
